Evalve
Engages in the design, development, manufacture, and marketing of devices that enable the repair of cardiac valves.
Launch date
Employees
Market cap
-
Enterprise valuation
€373m (Public information from Sep 2009)
Menlo Park California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | $15.9m | Series B | |
$35.0m | Series C | ||
$60.0m | Series D | ||
$410m Valuation: $410m | Acquisition | ||
| Total Funding | €101m | ||